Report Details:
15 Companies Covered
78 Pages
Spectral Computed Tomography Market Highlights
The Global Spectral Computed Tomography Market Size was estimated at 9.5 USD Billion in 2024. The Spectral Computed Tomography industry is projected to grow from 10.26 USD Billion in 2025 to 22.16 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 8.0% during the forecast period 2025 - 2035.
Spectral computed tomography (CT) also known as dual-energy CT (DECT) is an advanced form of computed tomography widely used in x-ray scanning technique. Spectral computed tomography is an advanced medical imaging device, which helps in the differentiation and characterization of tissues through the high quality of X-ray images. Spectral computed tomography (CT) contains two different energy spectra to provide concise images on the basis of material density.
The major key factors driving the market growth are increasing spending on the healthcare IT sector, technological advancements in the diagnostics sector, and increasing demand for diagnostic devices for precise imaging enhances the market growth. Also, the growing prevalence of cardiovascular and neurological diseases across the globe increase the demand for spectral computed tomography (CT) devices. However, factors such as high cost compared to conventional CT scan machines, availability of alternatives CT scan devices, and the less awareness about the products among the radiologists may hamper the market growth.
Segment Analysis
The global spectral computed tomography market is segmented into application and end user. On the basis of application, the global spectral computed tomography market has been segmented into oncology, cardiology, musculoskeletal disorders, and gastrointestinal diseases. Based on end user, the market has been segmented into diagnostic centers and hospitals & clinics.
Regional Analysis
The global spectral computed tomography market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Asia-Pacific is expected to hold the largest share of the global spectral computed tomography market. This is owing to the increasing patient population suffering from cancer and cardiovascular diseases and growing geriatric population suffering from numerous diseases are boosting the market growth in this region.
Explore In-depth Details: Spectral Computed Tomography Market Research Report
The Americas market holds the second-largest position in the global spectral computed tomography market owing to the increasing healthcare expenditure, and the presence of large number of medical devices companies in this region.
Europe is the third-largest region in the global spectral CT market. Factors such as growth in the medical device industry, the presence of developed economies, high per capita disposable income, and increased healthcare spending by consumers are driving the growth of the market in this region.
The spectral computed tomography market in the Middle East & Africa accounts the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018.
Market Players
MRFR recognizes the following companies as the key players in the global spectral computed tomography market— General Electric Company (US), Koninklijke Philips N.V. (Amsterdam, Netherlands), MARS Bioimaging Ltd (Christchurch, New Zealand), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd (China), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts).
Key Findings of the Study
- Technological advancements are enhancing imaging capabilities, leading to improved diagnostic accuracy.
- The demand for personalized medicine is driving innovations in spectral computed tomography applications.
- North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector.
- Key market drivers include the rising incidence of chronic diseases and the expansion of healthcare infrastructure.
